𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P53 alterations in benign and malignant ovarian cancer

✍ Scribed by Buttitta, F.; Gadducci, A.; Marchetti, A.; Pellegrini, S.; Morganti, M.; Parrini, D.; Castellani, C.; Facchini, V.

Book ID
123337215
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
144 KB
Volume
47
Category
Article
ISSN
0753-3322

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

p53 in malignant and benign liver lesion
p53 in malignant and benign liver lesions
✍ Zs. Schaff; I. SΓ‘rosi; C.C. Hsia; A. Kiss; E. Tabor πŸ“‚ Article πŸ“… 1995 πŸ› Elsevier Science 🌐 English βš– 874 KB
P53-specific T cell responses in patient
P53-specific T cell responses in patients with malignant and benign ovarian tumors: Implications for p53 based immunotherapy
✍ Annechien Lambeck; Ninke Leffers; Baukje-Nynke Hoogeboom; Wim Sluiter; Ineke Ham πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 214 KB

## Abstract Despite intensive treatment, 70% of the ovarian cancer patients will develop recurrent disease, emphasizing the need for new approaches such as immunotherapy. A promising antigenic target for immunotherapy in ovarian cancer is the frequently overexpressed p53 protein. The aim of the stu

p53 polymorphism in ovarian and breast c
p53 polymorphism in ovarian and breast cancer
✍ IanG. Campbell; DianaM. Eccles; Bridget Dunn; Michael Davis; Vivien Leake πŸ“‚ Article πŸ“… 1996 πŸ› The Lancet 🌐 English βš– 328 KB